Erythropoietin is effective in improving the anemia induced by imatinib mesylate therapy in patients with chronic myeloid leukemia in chronic phase (Q44908385)
scientific article
Language:
Current Data About Erythropoietin is effective in improving the anemia induced by imatinib mesylate therapy in patients with chronic myeloid leukemia in chronic phase
(P31) (Q13442814)
(P248)
(P698) 15160343
(P813) Thursday, December 7, 2017

(P50) (Q60394812)
(P1545) 8
(P1932) Hagop Kantarjian
(P248)
(P698) 15160343
(P813) Thursday, December 7, 2017

(Q66370727)
(P1545) 2
(P1932) Susan O'Brien
(P248)
(P698) 15160343
(P813) Thursday, December 7, 2017

(Q66380830)
(P1545) 6
(P1932) Mary Beth Rios
(P248)
(P698) 15160343
(P813) Thursday, December 7, 2017

(Q66380831)
(P1545) 4
(P1932) Francis Giles
(P248)
(P698) 15160343
(P813) Thursday, December 7, 2017

(Q60320900)
(P1545) 1
(P1932) Jorge Cortes
(P248)
(P698) 15160343
(P813) Thursday, December 7, 2017

(Q87650933)
(P1545) 7
(P1932) Moshe Talpaz
(P248)
(P698) 15160343
(P813) Thursday, December 7, 2017

(Q114427924)
(P1545) 5
(P1932) Jianquin Shan
(P248)
(P698) 15160343
(P813) Thursday, December 7, 2017

(P304) 2396-2402
(P248)
(P698) 15160343
(P813) Thursday, December 7, 2017

(P407) (Q1860)

(P433) 11
(P248)
(P698) 15160343
(P813) Thursday, December 7, 2017

(P478) 100
(P248)
(P698) 15160343
(P813) Thursday, December 7, 2017

(P577) Tuesday, June 1, 2004
(P248)
(P698) 15160343
(P813) Thursday, December 7, 2017

(P921) (Q729735)

(Q29496)
(P887)

(Q218706)
(P887)

(Q177094)
(P887)

(P1433) (Q326041)
(P248)
(P698) 15160343
(P813) Thursday, December 7, 2017

(P1476) "Erythropoietin is effective in improving the anemia induced by imatinib mesylate therapy in patients with chronic myeloid leukemia in chronic phase" (language: en)
(P248)
(P698) 15160343
(P813) Thursday, December 7, 2017

(P2093) Alfonso Quintas
(P1545) 3
(P248)
(P698) 15160343
(P813) Thursday, December 7, 2017

(P2860) (Q28277030)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FCNCR.20292
(P813) Thursday, January 7, 2021
(P887)

(Q33336718)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FCNCR.20292
(P813) Thursday, January 7, 2021
(P887)

(Q29547900)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FCNCR.20292
(P813) Thursday, January 7, 2021
(P887)

(Q43899710)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FCNCR.20292
(P813) Thursday, January 7, 2021
(P887)

(Q44189709)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FCNCR.20292
(P813) Thursday, January 7, 2021
(P887)

(Q43904522)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FCNCR.20292
(P813) Thursday, January 7, 2021
(P887)

(Q43977683)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FCNCR.20292
(P813) Thursday, January 7, 2021
(P887)

(Q34183674)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FCNCR.20292
(P813) Thursday, January 7, 2021
(P887)

(Q35095956)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FCNCR.20292
(P813) Thursday, January 7, 2021
(P887)

(Q44529440)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FCNCR.20292
(P813) Thursday, January 7, 2021
(P887)

(Q74805712)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FCNCR.20292
(P813) Thursday, January 7, 2021
(P887)

(Q40874955)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FCNCR.20292
(P813) Thursday, January 7, 2021
(P887)

(Q68865585)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FCNCR.20292
(P813) Thursday, January 7, 2021
(P887)

(Q25938997)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FCNCR.20292
(P813) Thursday, January 7, 2021
(P887)

(Q33358304)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FCNCR.20292
(P813) Thursday, January 7, 2021
(P887)

(Q44474954)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FCNCR.20292
(P813) Thursday, January 7, 2021
(P887)

(Q40654271)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FCNCR.20292
(P813) Thursday, January 7, 2021
(P887)

(Q44440140)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FCNCR.20292
(P813) Thursday, January 7, 2021
(P887)

other details